| | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C20H26N2 |
| Molar mass | 294.442 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Tetrindole was a drug candidate that functions by reversibly inhibiting monoamine oxidase A; it was first synthesized in Moscow in the early 1990s. [1] Tetrindole is similar in its chemical structure to pirlindole (Pyrazidol), and metralindole. [2]